Business & Regulation

Is your business prepared for Brexit? Here’s some advice from Nik Kotecha.

How will new guidance issued by the FDA affect drug importation?

Sitting Down With… Richard M. Johnson, President, and Chief Executive Officer, Parenteral Drug Association.

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.

The UK’s medicines regulator releases new guidance for Brexit.

What's new in business?

Kiran Mazumdar-Shaw shares the experiences that have helped shape her career, and the lessons learned along the way.

New forays into the pharma space and a billion-dollar discovery deal… What’s new in business?

Researchers identify several factors associated with shorter marketing exclusivity periods.

How can small molecule "degraders" help target disease-causing proteins?